Episode 194 -- Anti-Corruption Risks and Compliance Trends in Pharmaceutical and Medical Device Markets
May 16, 2021
26:40
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
The Justice Department and the SEC have a long history of focusing FCPA enforcement on pharmaceutical and medical device companies. Starting with a broad "industry sweep" nearly a decade ago, DOJ and the SEC have brought numerous enforcement actions. In response, drug and device companies have attempted to implement effective compliance programs.
In this Episode, Mike Volkov discusses FCPA enforcement trends and compliance strategies.